By browsing our site you agree to our use of cookies. You will only see this message once. Find out more

Waltham Forest CCG is seeking to commission a primary care-led service model for the monitoring and management of anticoagulation patients. The service is required to be delivered from a minimum of five sites across the borough, with at least three ...

Corrigendum

Notice for changes or additional information

Services

(Supplement to the Official Journal of the European Union, 2017/S 150-310391)

Section I: Contracting authority/entity

I.1)Name and addresses
NHS Waltham Forest Clinical Commissioning Group
Kirkdale House, 7 Kirkdale Road
London
E11 1HP
United Kingdom
Telephone: +44 2036881543
E-mail:
NUTS code: UKI5

Internet address(es):

Main address: http://www.walthamforestccg.nhs.uk/

Address of the buyer profile: http://www.walthamforestccg.nhs.uk/

Section II: Object

II.1)Scope of the procurement
II.1.1)Title:

Waltham Forest Anticoagulation Services.

II.1.2)Main CPV code
85100000
II.1.3)Type of contract
Services
II.1.4)Short description:

Waltham Forest CCG is seeking to commission a primary care-led service model for the monitoring and management of anticoagulation patients. The service is required to be delivered from a minimum of five sites across the borough, with at least three of these sites being local pharmacies. Initially the service will be responsible for the management of approximately 1200 stable patients on warfarin; the CCG will seek to work jointly with the provider and secondary care to further develop the anticoagulation pathway over the life of the contract, which may include extending the service to the monitoring of other types of anticoagulants. The service includes the provision of Point of Care Testing, a domiciliary service for patients who are housebound, and the use of INRstar software for dosing advice and data reporting. Initial 3 year contract from 1.1.2018 - 31.12.2020, with the option to extend for up to a further 2 years. Annual contract value is 292 000 GBP

Section VI: Complementary information

VI.5)Date of dispatch of this notice:
18/08/2017
VI.6)Original notice reference
Notice number in the OJ S: 2017/S 150-310391

Section VII: Changes

VII.1)Information to be changed or added
VII.1.2)Text to be corrected in the original notice
Section number: II.1.4)
Instead of:

Waltham Forest CCG is seeking to commission a primary care-led service model for the monitoring and management of anticoagulation patients. The service is required to be delivered from a minimum of five sites across the borough, with at least three of these sites being local pharmacies. Initially the service will be responsible for the management of approximately 1200 stable patients on warfarin; the CCG will seek to work jointly with the provider and secondary care to further develop the anticoagulation pathway over the life of the contract, which may include extending the service to the monitoring of other types of anticoagulants. The service includes the provision of Point of Care Testing, a domiciliary service for patients who are housebound, and the use of INRstar software for dosing advice and data reporting. Initial 3 year contract from 1.1.2018 - 31.12.2020, with the option to extend for up to a further 2 years. Annual contract value is 292 000 GBP

Read:

Waltham Forest CCG is seeking to commission a primary care-led service model for the monitoring and management of anticoagulation patients. The service is required to be delivered from a minimum of five sites across the borough, with at least three of these sites being local pharmacies. Initially the service will be responsible for the management of approximately 1200 stable patients on warfarin; the CCG will seek to work jointly with the provider and secondary care to further develop the anticoagulation pathway over the life of the contract, which may include extending the service to the monitoring of other types of anticoagulants. The service includes the provision of Point of Care Testing, a domiciliary service for patients who are housebound, and the use of INRstar software for dosing advice and data reporting. Initial 3 year contract from 1.2.2018 - 31.1.2021, with the option to extend for up to a further two years. Annual contract value is 292 000 GBP.

VII.2)Other additional information:

Due to the level of interest in this project and the need to ensure sufficient time to identify and mobilise a provider, the start date for this contract will now be 1st February 2018.”

To view this notice, please click here:

https://www.delta-esourcing.com/delta/viewNotice.html?noticeId=274546325

GO Reference: GO-2017818-PRO-10860605.